Conduent Applies GenAI to Revolutionize Detection of Reportable Events and Sets New Standard for FDA Compliance
Conduent Incorporated (Nasdaq: CNDT), a global provider of technology-driven business solutions and services, announced the launch of a generative AI solution designed to transform how reportable events are identified and managed within the pharmaceutical and life sciences sectors.
Powered by Microsoft Azure OpenAI, the innovation automates the complex process of reportable event detection across all customer interaction channels, enabling companies to achieve higher efficiency and compliance standards required by the U.S. Food and Drug Administration (FDA).
“Powered by Microsoft Azure OpenAI, the new solution automates reportable event detection for Pharma & Life Sciences companies across every customer channel.”
Media Contact
- Sean Collins, Conduent
- Phone: +1-310-497-9205
- Email: [email protected]
Investor Relations
- Joshua Overholt, Conduent
- Email: [email protected]
Author’s summary: Conduent integrates generative AI and Microsoft Azure to automate FDA reportable event detection, helping pharmaceutical and life sciences organizations improve compliance and operational intelligence.